Terns Pharmaceuticals, Inc. Total Assets
Terns Pharmaceuticals, Inc. had Total Assets of $1.03 billion as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-03-30
- 2025-12-31: Assets $1.03B.
- 2025-09-30: Assets $301.65M.
- 2025-06-30: Assets $320.42M.
- 2025-03-31: Assets $339.31M.
| Period end | Assets |
|---|---|
| 2025-12-31 | $1.03B 10-K · filed 2026-03-30 |
| 2025-09-30 | $301.65M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $320.42M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $339.31M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $363.93M 10-K · filed 2026-03-30 |
| 2024-09-30 | $378.23M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $230.88M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $246.77M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $268.52M 10-K · filed 2025-03-20 |
| 2023-09-30 | $271.69M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $289.70M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $301.29M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $287.03M 10-K · filed 2024-03-14 |
| 2022-09-30 | $192.59M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $144.86M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $156.67M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $168.07M 10-K · filed 2023-03-27 |
| 2021-09-30 | $179.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $188.01M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $199.24M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $92.29M 10-K · filed 2022-03-07 |